Marsh & McLennan Companies, Inc. (MRSH) — Fair Value Analysis

Base-case fair value (P50): $197.73 · Current price: $189.69 · Verdict: Fairly Valued

The Verdict on MRSH

Marsh & McLennan Companies, Inc. (MRSH), a prominent player in the Financial Services sector, is currently assessed as Fairly Valued based on our comprehensive Monte Carlo simulations. At its $189.69, MRSH trades very close to its median fair value (P50) of $197.73. This proximity suggests the market is largely aligned with our intrinsic valuation, with a modest +4.2% relative to the median. The company’s operational and financial health, categorized as an "average" quality tier compared to its sector peers, further supports this balanced assessment, indicating no significant mispricing at current levels.

How MRSH stacks up against Financial Services

Within the diverse Financial Services sector, MRSH's "average" quality tier signifies a solid, though not exceptional, performance profile when benchmarked against its industry cohorts. The Monte Carlo simulation, by modeling thousands of forward scenarios, determines that $189.69 for an "average" quality Financial Services company like MRSH is in line with its intrinsic value, validated by the $197.73 fair value. The +4.2% reinforces this perspective, implying that while there may be some incremental upside, it's not substantial enough to categorize MRSH as significantly undervalued within its sector at $189.69. Investors should recognize that an "average" quality tier combined with fair valuation suggests stable positioning without compelling discounts or premiums.

What this means for investors

For investors considering MRSH, the current assessment of Fairly Valued suggests that the stock at $189.69 has limited immediate alpha potential based solely on valuation discrepancies. The tight spread between $189.69 and our $197.73 fair value, reflected in the +4.2%, indicates that much of MRSH's intrinsic value is already priced in. While there isn't a significant overvaluation, neither is there a compelling undervaluation that would attract deep-value investors. FairCurve analysis, accounting for thousands of scenarios, provides this granular insight. For a comprehensive understanding, including the full probabilistic distribution of fair value, and to track MRSH's fair value as new fundamentals are released, sign up for a free FairCurve account.

Frequently Asked Questions

Is MRSH overvalued or undervalued right now?

Based on our Monte Carlo simulations, MRSH is currently assessed as Fairly Valued, with its current price of $189.69 trading very close to its median fair value (P50) of $197.73.

What is the bear case and bull case for MRSH?

The full Monte Carlo distribution, including bear (P10) and bull (P90) targets and the probability of upside, is available with a free FairCurve account for a more detailed scenario analysis.

How does FairCurve calculate MRSH's fair value?

FairCurve calculates MRSH's fair value using sophisticated Monte Carlo simulations, modeling thousands of forward-looking scenarios to derive a probabilistic distribution of its intrinsic worth.

How can I track MRSH's fair value as it changes?

You can add MRSH to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation when new earnings data or significant fundamental changes are released.